XML 62 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION - Schedule of Disaggregation of Total Net Product Revenues by Product (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue from External Customer [Line Items]    
Revenue $ 648,833 $ 596,415
Product    
Revenue from External Customer [Line Items]    
Revenue 637,815 586,426
VIMIZIM    
Revenue from External Customer [Line Items]    
Revenue 192,520 189,192
VOXZOGO    
Revenue from External Customer [Line Items]    
Revenue 152,889 87,836
NAGLAZYME    
Revenue from External Customer [Line Items]    
Revenue 105,629 123,021
PALYNZIQ    
Revenue from External Customer [Line Items]    
Revenue 75,709 62,352
BRINEURA    
Revenue from External Customer [Line Items]    
Revenue 39,047 39,144
KUVAN    
Revenue from External Customer [Line Items]    
Revenue 35,910 50,478
ALDURAZYME    
Revenue from External Customer [Line Items]    
Revenue 35,262 34,403
ROCTAVIAN    
Revenue from External Customer [Line Items]    
Revenue 849 0
Royalty and other revenues    
Revenue from External Customer [Line Items]    
Revenue $ 11,018 $ 9,989